Answers are grounded in this paper and cite their sources.
In 12-18% of adult patients, treatment with benznidazole for chronic Chagas disease has to be discontinued because of side-effects. We identified and analysed a cohort of 81 adult patients with three positive tests for Trypanosoma cruzi infection and serological monitoring following incomplete treatment with benznidazole for a median of 10 days. Twenty percent of these patients (16/81) met the criteria of cure, showing that the optimal schedule of benznidazole administration remains to be determined.
No takes yet. Share an insight, caveat, or question.
Alvarez et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: